P515 Evaluation of treatment persistence of vedolizumab among Finnish inflammatory bowel disease patients in real-life clinical practice (FINVEDO).

Added 1350 days ago (09.02.2017)
Authors: Ylisaukko-Oja T, Eberl A, Aaltonen J, Nuutinen H, Blomster T, Jussila A, Pajala M, Jokelainen J, Herrala S, Tamminen K, Sipponen T
PubMed id: 28175160
Read article